HIGHLIGHTS
- who: Danai-Thomais Kostourou et al. from the First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki have published the research: The Role of Angiotensin Receptor Blockers in the Personalized Management of Diabetic Neuropathy, in the Journal: (JOURNAL)
- what: Emerging experimental and clinical data suggest than ARBs might be a useful tool for preventing and delaying the progression of diabetic neuropathy.
SUMMARY
The Role of Type 2 diabetes_mellitus (T2DM) is becoming increasingly prevalent and currently affects approximately 14.3% of the adult the authors population. Diabetic neuropathy is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.